CANCER-RELATED ANEMIA
Clinical trials for CANCER-RELATED ANEMIA explained in plain language.
Never miss a new study
Get alerted when new CANCER-RELATED ANEMIA trials appear
Sign up with your email to follow new studies for CANCER-RELATED ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to boost red blood cells in cancer patients
Symptom relief Not yet recruitingThis Phase 2 trial tests an oral drug called AND017 for anemia (low red blood cells) in cancer patients who are not receiving chemotherapy. The study will enroll 36 participants to see if different doses of AND017 can safely raise hemoglobin levels over 6 weeks. The goal is to re…
Matched conditions: CANCER-RELATED ANEMIA
Phase: PHASE2 • Sponsor: Kind Pharmaceuticals LLC • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
New pill aims to beat chemo fatigue: AND017 trial launches
Symptom relief Not yet recruitingThis Phase 2 trial tests an oral drug called AND017 for cancer-related anemia caused by chemotherapy. About 36 adults with non-myeloid cancers and low hemoglobin will take AND017 three times a week for 6 weeks. The goal is to see if it safely raises hemoglobin levels and reduces …
Matched conditions: CANCER-RELATED ANEMIA
Phase: PHASE2 • Sponsor: Kind Pharmaceuticals LLC • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC